Showing results (761-770 of 995) with videos related to

Sort By:
Pageof 100
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 6, 2003
Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinomaKarine Llinares, Fabienne Escande, Sébastien Aubert, et al.
Cancer Letters|March 26, 2013
Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapyTomohiro Shimizu, María P Torres, Subhankar Chakraborty, et al.
Biomaterials|June 9, 2016
Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasisYan Wang, Sushil Kumar, Satyanarayana Rachagani, et al.
The American Journal of Gastroenterology|January 13, 2006
Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in ratsUwe A Wittel, Krishan K Pandey, Mahefatiana Andrianifahanana, et al.
Pancreas|August 4, 2001
Transdifferentiation of human islet cells in a long-term cultureB M Schmied, A Ulrich, H Matsuzaki, et al.
Cancer Genetics|July 15, 2018
Non-invasive early detection of malignant pulmonary nodules by FISH-based sputum testDekel Shlomi, Nir Peled, Yehuda A Schwarz, et al.
Cancer Letters|March 30, 2023
Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancerKathryn M Muilenburg, Carly C Isder, Prakash Radhakrishnan, et al.
Biochimica Et Biophysica Acta|March 25, 2010
Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucinsSamuel B Ho, Ying Luu, Laurie L Shekels, et al.
Cancer Letters|April 6, 2012
Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolismMaría P Torres, Satyanarayana Rachagani, Vinee Purohit, et al.
Oncotarget|June 4, 2016
Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasiaSujit Suklabaidya, Biswajit Das, Syed Azmal Ali, et al.
Pageof 100